Dacoplice 30Mg Bottle Of 30 Tablets
30 Tablet(s) in BottleMRP ₹61000.00
₹54500.00
11% OFF
Made by
PFIZER PRODUCT INDIA PRIVATE LIMITED
Dosage
TABLET
Expiry
Product Summary
| Uses | Metastatic non-small cell lung cancer (NSCLC) with EGFR exon 19 deletion or exon 21 L858R substitution mutations |
| Therapy | Anti-neoplastic |
| Side effects | Diarrhea, rash, paronychia (nail bed infection), dry skin, stomatitis, decreased appetite, fatigue, nausea |
| Salt Content | Dacomitinib(30.0 Mg) |
Assurance
available
Regulated
Medical Description
Dacoplice tablet contains dacomitinib, a second-generation irreversible EGFR tyrosine kinase inhibitor (TKI). It irreversibly blocks EGFR (HER1), HER2, and HER4 receptors, helping inhibit cancer cell growth and proliferation. It is available as a film-coated tablet for oral use.
Dacoplice tablet is used as a first-line treatment for adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumours harbour specific EGFR gene mutations (specifically, EGFR exon 19 deletion or the L858R substitution in exon 21). Before starting treatment, an appropriate validated test should confirm the presence of an eligible EGFR mutation.
Treatment is started and supervised by a specialist doctor, and it continues as long as the cancer keeps responding and side effects remain manageable.
Uses
Contraindications
- If you are allergic to dacomitinib or any other ingredient in this medicine, as a serious allergic reaction may occur.
- If you are pregnant, the active drug can cause severe harm or death to an unborn baby.
- If you are currently breastfeeding, it can develop potential adverse effects in nursing infants.
Side effects
- Frequent loose or watery stools (diarrhoea)
- Skin reactions, including acne-like rash (acneiform dermatitis), dry skin, redness, and skin peeling
- Inflammation and infection around the nails (paronychia)
- Mouth sores, ulcers, and lip inflammation (stomatitis)
- Reduced appetite and weight loss
- Feeling sick (nausea) and vomiting
- Dry eyes, eye irritation, and conjunctivitis
- Hair loss or hair thinning (alopecia)
- Severe tiredness and physical weakness (fatigue)
- Raised liver enzymes on blood test panels
- Changes in taste (dysgeusia)
- Nosebleeds (epistaxis)
- Abnormal hair growth, such as excessive eyelash growth or brittle nails
- Dehydration resulting from persistent diarrhoea or nausea
- Severe Diarrhoea: Intense or persistent diarrhoea leading to severe dehydration, low blood pressure, and kidney injury, which requires prompt medical assessment and appropriate treatment.
- Interstitial Lung Disease (ILD) / Pneumonitis: Severe, potentially fatal lung inflammation; symptoms include new or worsening shortness of breath, cough, or fever. If ILD/pneumonitis is confirmed, treatment should be permanently discontinued.
- Severe Skin Reactions: Extensive rash, skin blistering, or skin peeling covering large areas of the body that may require treatment interruption or dose reduction.
Directions for Use
- Take Dacoplice tablet exactly as your doctor tells you.
- You can take Dacoplice tablet with or without food.
- Swallow the tablets whole with a glass of water. Do not chew, crush, or split them.
- If you vomit or miss a dose, do not take an extra tablet; take your next dose at the usual scheduled time the following day.
Storage and disposal
- Store tablets at the storage temperature specified on the product packaging/prescribing information.
- Keep the tablets in their original packaging to protect them from moisture and light.
- Keep out of reach of children and pets.
- Dispose of unused/expired medicines properly.
Quick Tips
- Keep anti-diarrheal medication (such as loperamide)available if advised by your doctor, and follow the recommended treatment for diarrhoea.
- Apply alcohol-free moisturizing creams regularly to your skin and hands to manage dry skin and prevent acne-like skin rashes.
- Avoid direct sunlight and wear protective clothing and sunscreen outdoors, as Dacoplice tablet can make your skin more sensitive to sunlight.
- Practice good oral hygiene by using a soft toothbrush and alcohol-free mouthwashes to help prevent painful mouth sores.
- Contact your doctor immediately if you develop new or worsening shortness of breath, cough, or chest pain, as these may signal severe lung inflammation.
- Women who could become pregnant must use effective birth control during treatment and for the period recommended in the prescribing information after the last dose.
Dosage
Overdose
Missed a Dose
How does this medicine work?
Interactions
Interactions with other medicines
- Strong CYP2D6 substrates with narrow therapeutic indices (such as procainamide, flecainide, or certain tricyclic antidepressants) may have increased blood levels when taken with Dacoplice tablet, potentially increasing the risk of adverse effects.
- Strong CYP3A4 inducers (such as rifampicin, carbamazepine, phenytoin, and St. John's Wort) can significantly lower the concentration of Dacoplice tablet in your blood and reduce its effectiveness.
- Proton pump inhibitors (PPIs, like omeprazole or pantoprazole) can reduce the absorption of Dacoplice tablet. If acid-reducing therapy is required, an antacid or H2-receptor antagonist may be considered according to your doctor's advice.
- Always tell your doctor about all prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you take before starting treatment.
Interactions with food items
Frequently Asked Questions (FAQs)
References:
- Vizimpro (dacomitinib) film-coated tablets: prescribing information [Internet]. New York, NY: Pfizer Inc.; 2022.
- Electronic Medicines Compendium (EMC). Vizimpro 15 mg, 30 mg, and 45 mg film-coated tablets [Summary of Product Characteristics]. London: Datapharm; 2023.
- National Center for Biotechnology Information. PubChem compound summary for CID 11556711: Dacomitinib [Internet]. Bethesda, MD: National Library of Medicine; 2026.
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:DACOPLICE
Manufacturer Name:PFIZER PRODUCT INDIA PRIVATE LIMITED
Address:Pfizer manufacturing deutschiand gmbh, betriebsstiatte freiburg, mooswaldallee 1,79090 freiburg, germany.
Country of Origin:Germany
Vendor Details
Fulfillment Information: Dacoplice 30 MG Tablet (30) will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.




















